Burak Yasin Aktas

11PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutrigenomics and personalised nutritionCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 26, 2026
Clinical Characteristics and Survival Outcomes of a Clinically Defined Treatment-Emergent Neuroendocrine/Aggressive-Variant Prostate Cancer Phenotype: A Retrospective Study.

|Sep 26, 2026
Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis.

|Jul 14, 2026
Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer.

|Jun 27, 2025
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Hakan Taban, Mustafa Erman, Deniz Can Guven

|Mar 13, 2024
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy.

Gürkan Güner, Levent Özçakar, Yusuf Baytar

|Mar 01, 2023
Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study.

Nesligul Ozdemir, Burak Y Aktas, Ahmet Gulmez

Pageof 2

Frequent Collaborators

7 joint publications

Denizcan Güven

5 joint publications

Omer Dizdar

4 joint publications

Mustafa Erman

4 joint publications

Hakan Taban